The Government has just announced a new wave of funding to promote the use of innovative medical and digital technology in the NHS.
This £86 million pound investment will support UK business, particularly small and medium-sized enterprises, to develop and test their medical innovations. By doing so, the Government hopes that this will break down the barriers that prevent implementation and ensure innovation can improve clinical pathways and patient experiences.
Health Minister Lord O’Shaughnessy said:
The government’s ambition is that NHS patients get world-leading, life-changing treatments as fast as possible.
That can’t happen unless we support medical innovation and tear down the barriers – like speed to market and access to funding – that can get in the way, especially for SMEs.
Our investment in innovation shows how much we value the UK life sciences sector.
The funding will be separated into 4 distinct strands, with funding delivered to Academic Health Science Networks, a Digital Health Technology Catalyst, SMEs and for the Pathway Transformation Fund.
At Una Health we welcome this announcement as an indication that Government intends to support innovation and pathway development in medical technology, and that it values the contribution of small and medium enterprise in this area.
We strive to work with our customers and strategic partners to develop novel pathways using accurate and reliable point of care testing. Our main aims are to improve diagnosis, reduce intervention and present unique patient access points. This funding stream represents an opportunity to level the playing field for small business trying to promote innovative ideas to the healthcare market, and we are excited to find out more.
Fiona Jacobs, Managing Director, Una Health.
Medical innovation, and in particular point of care diagnostics, can have a revolutionary effect on the delivery of care pathways but often the process of implementation is difficult and there are many obstacles to overcome. There are many opportunities to be gained by investing in innovation in this area, for example; reducing admissions in accident and emergency during winter season; managing COPD patients in their own home; or delivering diagnostic services in novel locations such as community pharmacy.
To read the full Government statement on this funding announcement please click here.